Literature DB >> 2452946

Studies on the mechanism of the vasodilator action of nicorandil.

D J Lefer1, A M Lefer.   

Abstract

Nicorandil, a compound having structural similarities to some of the organic nitrates, was studied for its mechanism of vasodilation. Nicorandil is thought to be a K+ channel opening agent. However, little is known about its receptor activation profile, its endothelial dependence, and its effects in atherosclerotic vessels. Nicorandil, at 0.2 to 5 x 10(-6) M, relaxed norepinephrine precontracted rabbit aortic rings in a concentration-dependent manner. Moreover, nicorandil relaxed aortic rings to the same extent in the presence and absence of an intact endothelium. However, nicorandil's effect was diminished in aortic rings from atherosclerotic rabbits. The vasorelaxation action of nicorandil was unaffected by the cyclooxygenase inhibitor ibuprofen or the lipoxygenase inhibitor propyl gallate, suggesting that nicorandil does not act via the release of a vasodilator eicosanoid. Although the nicorandil effect was not influenced by atropine, a muscarinic receptor antagonist, it was significantly attenuated by methylene blue, a guanyl cyclase inhibitor. Thus, nicorandil has some properties in common with organic nitrates and with K+ channel activators but appears to be a unique type of vasodilator.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452946     DOI: 10.1016/0024-3205(88)90031-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  The dualistic mode of action of the vasodilator drug, nicorandil, differentiated by glibenclamide in 86Rb flux studies in rabbit isolated vascular smooth muscle.

Authors:  V A Kreye; T Lenz; U Theiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

2.  Nicorandil prevents Gαq-induced progressive heart failure and ventricular arrhythmias in transgenic mice.

Authors:  Masamichi Hirose; Yasuchika Takeishi; Tsutomu Nakada; Hisashi Shimojo; Toshihide Kashihara; Ayako Nishio; Satoshi Suzuki; Ulrike Mende; Kiyoshi Matsumoto; Naoko Matsushita; Eiichi Taira; Fumika Sato; Mitsuhiko Yamada
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 3.  Nicorandil: A drug with ongoing benefits and different mechanisms in various diseased conditions.

Authors:  Lamiaa Ahmed Ahmed
Journal:  Indian J Pharmacol       Date:  2019-11-26       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.